Professor Deb White is Deputy Director of SAHMRI. The Director: Precision Cancer Medicine Theme (SAHMRI), and Scientific Group Leader of the Acute Lymphoblastic Leukaemia Genomics and Functional Genomics Research Group. Deb’s research focus is genomics and rationally targeted therapies in Acute Lymphoblastic Leukaemia (ALL). She has presented > 200 papers at scientific meetings and authored >160 scientific publications.

Deb established, led and federated the ALL Stream of The Australian Genomics Health Alliance. She is an elected member of the Board of Directors for both the Australian and New Zealand Children’s Haem-Oncology Group (ANZCHOG)and the Australasian Leukaemia Lymphoma Group (ALLG) and an invited member of the Precision Medicine Committee, Commission on Excellence and Innovation in Health (CEIH) SA Health. Internationally, Deb is the Australian representative to the The Variant Interpretation for Cancer Collaboration (VICC) Executive Group {An initiative of the Global Alliance for Genomics and Health (GA4GH)}.

She has received a number of awards: Australian Society for Medical Research (ASMR) Leading Light, the University of Adelaide James McWha medal, the prestigious NHMRC Research Excellence Award and the Beat Cancer Women in Leadership Award.